Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
Taishi Hata, Mamoru Uemura, Katsuki Danno, Shinichi Yoshioka, Chu Matsuda, Yoshinori Kagawa, Tatsushi Shingai, Yozo Suzuki, Mitsuyoshi Tei, Tsukasa Tanida, Takamichi Komori, Shu Okamura, Hirofumi Ota, Hiroyoshi Takemoto, Takayuki Ogino, Norikatsu Miyoshi, Hirofumi Yamamoto, Kohei Murata, Yuichiro Do · 2024
Read Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer by Taishi Hata, Mamoru Uemura, Katsuki Danno, Shinichi Yoshioka, Chu Matsuda, Yoshinori Kagawa, Tatsushi Shingai, Yozo Suzuki, Mitsuyoshi Tei, Tsukasa Tanida, Takamichi Komori, Shu Okamura, Hirofumi Ota, Hiroyoshi Takemoto, Takayuki Ogino, Norikatsu Miyoshi, Hirofumi Yamamoto, Kohei Murata, Yuichiro Do (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11531565.txt.
Description
Adjuvant oxaliplatin plus capecitabine (XELOX) therapy is recommended for patients with curatively resected colon cancer. However, prospective data on its practical application in Japanese patients are limited. Therefore, we aimed to conduct a long-term clinical evaluation of the efficacy and safety of adjuvant XELOX in patients with curatively resected stage III colon cancer (MCSCO-1024).
Catalog record
| CREATOR | Taishi Hata, Mamoru Uemura, Katsuki Danno, Shinichi Yoshioka, Chu Matsuda, Yoshinori Kagawa, Tatsushi Shingai, Yozo Suzuki, Mitsuyoshi Tei, Tsukasa Tanida, Takamichi Komori, Shu Okamura, Hirofumi Ota, Hiroyoshi Takemoto, Takayuki Ogino, Norikatsu Miyoshi, Hirofumi Yamamoto, Kohei Murata, Yuichiro Do |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |